These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14645948)

  • 1. "Keep a low profile": pesticide residue, additives, and freon use in Australian tobacco manufacturing.
    Chapman S
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii45-53. PubMed ID: 14645948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.
    Velicer C; Lempert LK; Glantz S
    Tob Control; 2015 Sep; 24(5):469-80. PubMed ID: 24920577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Conclusions about exposure to ETS and health that will be unhelpful to us": how the tobacco industry attempted to delay and discredit the 1997 Australian National Health and Medical Research Council report on passive smoking.
    Trotter L; Chapman S
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii102-6. PubMed ID: 14645955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s.
    Carter SM; Chapman S
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii23-30. PubMed ID: 14645945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "A deep fragrance of academia": the Australian Tobacco Research Foundation.
    Chapman S; Carter SM; Peters M
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii38-44. PubMed ID: 14645947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Can't stop the boy": Philip Morris' use of Healthy Buildings International to prevent workplace smoking bans in Australia.
    Chapman S; Penman A
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii107-12. PubMed ID: 14645956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Avoid health warnings on all tobacco products for just as long as we can": a history of Australian tobacco industry efforts to avoid, delay and dilute health warnings on cigarettes.
    Chapman S; Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii13-22. PubMed ID: 14645944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers.
    Pauly JL; Mepani AB; Lesses JD; Cummings KM; Streck RJ
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I51-61. PubMed ID: 11893815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From legitimate consumers to public relations pawns: the tobacco industry and young Australians.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii71-8. PubMed ID: 14645951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tobacco industry and pesticide regulations: case studies from tobacco industry archives.
    McDaniel PA; Solomon G; Malone RE
    Environ Health Perspect; 2005 Dec; 113(12):1659-65. PubMed ID: 16330343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling pesticide residues in tobacco leaves for improving life cycle inventory analysis of pesticides in the cigarette industry.
    Li Z
    Sci Total Environ; 2022 Nov; 845():157267. PubMed ID: 35820521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations.
    Velicer C; Glantz SA
    PLoS One; 2015; 10(12):e0142032. PubMed ID: 26717245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open doorway to truth: legacy of the Minnesota tobacco trial.
    Hurt RD; Ebbert JO; Muggli ME; Lockhart NJ; Robertson CR
    Mayo Clin Proc; 2009 May; 84(5):446-56. PubMed ID: 19411441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
    Cummings KM; Morley CP; Hyland A
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of pesticides and veterinary drugs in Australian cattle: verification of the residue control system.
    Lutze J; Derrick J; Korth W; MacLachlan DJ
    Food Addit Contam Part B Surveill; 2009; 2(2):99-111. PubMed ID: 24785172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "If we can just 'stall' new unfriendly legislations, the scoreboard is already in our favour": transnational tobacco companies and ingredients disclosure in Thailand.
    MacKenzie R; Collin J; Sriwongcharoen K; Muggli ME
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii79-87. PubMed ID: 15564225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making big tobacco give in: you lose, they win.
    Wander N; Malone RE
    Am J Public Health; 2006 Nov; 96(11):2048-54. PubMed ID: 17018823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.